Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Cancer medicines outcomes programme: better use of data to understand outcomes in a local population

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: LASKEY, Jennifer (NHS Greater Glasgow and Clyde, PPSU)
  • Co-author(s): Jennifer Laskey
    Yvonne Semple: PPSU, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
    Olivia Wu: Health economics, University of Glasgow, Glasgow, United Kingdom
    Julie Clarke: PPSU, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
    Kelly baillie: PPSU, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
    Tanja Mueller: Pharmacy, University of Strathclyde, Glasgow, United Kingdom
    Jiafeng Pan: Pharmacy, University of Strathclyde, Glasgow, United Kingdom
    Rob Jones: medicine, University of Glasgow, Glasgow, United Kingdom
    Ashita Waterston: medicine, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
    Marion Bennie: Pharmacy, University of Strathclyde, Glasgow, United Kingdom
  • Abstract:

    Background

    Cancer medicines account for the highest proportion of new medicines introduced within NHS Scotland each year.  Most information about efficacy and safety of new medicines is derived from clinical trials.  There is an increasing interest in ‘real world’ data to understand local population outcomes.1,2,3

    Methods

    Melanoma and prostate cancer

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses